Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Selective estrogen receptor modulators (SERMs)].

Toshio Matsumoto1

  • 1University of Tokushima Graduate School of Health Biosciences, Department of Medicine and Bioregulatory Sciences.

Clinical Calcium
|September 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocolized Weaning From Mechanical Ventilation in the PICU: A Systematic Review and Meta-Analysis.

Pediatric pulmonology·2026
Same author

Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

The impact of PEEP on mechanical power and driving pressure in children with pediatric acute respiratory distress syndrome.

Pediatric pulmonology·2024
Same author

The Impact of Increased PEEP on Hemodynamics, Respiratory Mechanics, and Oxygenation in Pediatric ARDS.

Respiratory care·2024
Same author

Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1.

International journal of molecular sciences·2024
Same author

Osteoporotic fracture risk in women with breast cancer treated with aromatase inhibitors: a health insurance claims database study in Japan.

Expert opinion on pharmacotherapy·2024
Same journal

[The frontier of adipocyte biology, cold environment induces thermogenic genes via epigenomic switch.]

Clinical calcium·2019
Same journal

[Sequential treatment of osteoporosis with anti-sclerostin.]

Clinical calcium·2019
Same journal

[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]

Clinical calcium·2019
Same journal

[Wnt signaling in myeloma.]

Clinical calcium·2019
Same journal

[Fate decision of hematopoietic stem cells by Wnt signaling.]

Clinical calcium·2019
Same journal

[Control of inflammatory bone destruction by targeting the Wnt signaling pathway.]

Clinical calcium·2019
See all related articles

Selective estrogen receptor modulators (SERMs) offer tissue-selective benefits for osteoporosis treatment. Raloxifene (RLX) prevents fractures but requires careful consideration of stroke risk and treatment duration.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Oncology

Context:

  • Selective estrogen receptor modulators (SERMs) modulate estrogen receptor (ER) activity, acting as agonists or antagonists in a tissue-specific manner.
  • SERMs are designed to provide beneficial estrogen-like effects for conditions such as osteoporosis while mitigating risks associated with estrogen, like breast cancer.

Purpose:

  • To critically evaluate the benefits and risks of SERMs, specifically raloxifene (RLX), for osteoporosis treatment in postmenopausal women.
  • To inform decisions regarding the optimal timing, duration, and patient selection for SERM therapy in managing osteoporosis.

Summary:

  • Raloxifene (RLX) has demonstrated efficacy in preventing vertebral fractures in osteoporotic postmenopausal women.
  • RLX shows a significant reduction in the incidence of ER-positive invasive breast cancer, uterine cancer, and thromboembolic events.

Related Experiment Videos

  • While RLX does not impact overall cardiovascular events or mortality, a slight increase in stroke mortality has been observed.

    • Impact:

    • Provides a framework for personalized SERM treatment strategies in osteoporosis management.
    • Highlights the need for careful risk-benefit assessment considering individual patient profiles.
    • Contributes to informed clinical decision-making regarding SERM therapy for postmenopausal bone health and cancer prevention.